Group items tagged

Gut microbes-the collection of bacteria and other organisms that inhabit our intestines-have been shown to play a role in a wide variety of conditions from asthma to obesity. But researchers still don't know precisely how they contribute to obesity. To gain a better understanding, a team led by physiologist Mirko Trajkovski from the University of Geneva in Switzerland has been following up on any leads he can to learn about the link between these microbes and metabolism. Trajkovski knew from past research that getting rid of some gut bacteria in mice makes them less able to maintain their internal body temperature in the cold. He wondered whether there might be a connection between gut microbes, external temperature, and weight control.

By observing how the cells in the zebrafish's skin responded to injury, the Duke team learned a lot about the skin regeneration process and were surprised by its complexity. They saw that in the hours following a fin amputation, for example, zebrafish regenerated skin through three different mechanisms: the "recruitment" of spare skin cells from other areas, a temporary doubling in size in some pre-existing cells, and the creation of completely new cells.

Hear from some of the country's leading scientists and medical experts who talk about why animal research is critical for medical progress and the advancement of both human and animal health.

The researchers, Eicke Latz at the University of Bonn and colleagues, followed up on the parents' hypothesis and found that in mice, cyclodextrin indeed blocked plaque formation, melted away plaques that had already formed in arteries, reduced atherosclerosis-associated inflammation, and revved up cholesterol metabolism-even in rodents fed cholesterol-rich diets. In petri dish-based tests, the researchers found that the drug seemed to have the same effects on human cells and plaques.

Scientists may debate the accuracy of this equivalency, but most people agree that humans live many times longer than their furry friends. And, as it happens, these friends have features that uniquely qualify them to help us speed biomedical research.

Like humans, some golden retrievers develop Duchenne muscular dystrophy (DMD), a hereditary muscle wasting condition that begins early in life. Using gene therapy, scientists were able to restore muscle function in dogs with the disease, according to a study published today (July 25) in Nature Communications.

In the study, published Monday (May 1) in Nature Biotechnology,  Luo and colleagues set their sights on two fusions genes they had previously found to be associated with prostate cancer and various forms of rapid and invasive cancer, including liver tumors. Using a modified CRISPR-Cas9 tool that creates a single- rather than double-stranded break in DNA, they targeted the chromosomal breakpoints that form these fusion genes and replaced fusion DNA with a gene encoding the enzyme HSV1-tk. This enzyme effectively kills tumor cells by converting the drug ganciclovir into its active form, which then blocks DNA synthesis and leads to cell death. (Ganciclovir is used to treat cytomegalovirus in humans.)

Say a red gummy bear has a baby with a yellow gummy bear - what percentage of red and yellow do the parents give to their children? Well, assuming gummy bear genetics works the same way we do, they'll have one set of chromosomes from their mum and one from their dad - so 50 percent from each - easy!